Mallinckrodt Plc Quick Ratio (MNKKQ) starting from the second quarter 2026 to second quarter 2021, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Mallinckrodt Plc  (MNKKQ)

Mallinckrodt Plc's Quick Ratio

MNKKQ's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 1.63 above Mallinckrodt Plc average.

Within Major Pharmaceutical Preparations industry 493 other companies have achieved higher Quick Ratio than Mallinckrodt Plc in second quarter 2026. While Quick Ratio total ranking has improved so far during the Q2 2026 to 3630, from total ranking in the second quarter 2025 at 4317.

Explain Quick Ratio?
How much Cash & cash equivalents MNKKQ´s has?
What are MNKKQ´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MNKKQ Quick Ratio (Jun 30 2026)
Q2		 (Jun 27 2025)
Q2		 (Dec 27 2024)
Q4		 (Apr 01 2022)
Q2		 (Dec 31 2021)
Q1
Y / Y Current Liabilities Change -70.97 % -90.39 % -94.89 % -18.46 % -49.06 %
Y / Y Cash & cash equivalent Change -20.01 % -70.49 % -72.87 % 26.66 % 25.63 %
Quick Ratio MRQ 1.63 2.05 2.89 0.74 0.59
MNKKQ's Total Ranking # 3630 # 4317 # 3850 # 4055 # 4123
Seq. Current Liabilities Change 246.23 % 61.83 % -93.62 % -18.82 % 14.6 %
Seq. Cash & cash equivalent Change 175.63 % 14.63 % -75.06 % 1.51 % 1.69 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 494
Healthcare Sector # 889
Overall Market # 2576


Quick Ratio Statistics
High Average Low
2.89 0.6 0.13
(Dec 27 2024)   (Sep 25 2020)




Financial Statements
Mallinckrodt Plc's Current Liabilities $ 661 Millions Visit MNKKQ's Balance sheet
Mallinckrodt Plc's Cash & cash equivalent $ 1,076 Millions Visit MNKKQ's Balance sheet
Source of MNKKQ's Sales Visit MNKKQ's Sales by Geography


Cumulative Mallinckrodt Plc's Quick Ratio

MNKKQ's Quick Ratio for the trailling 12 Months

MNKKQ Quick Ratio

 (Jun 30 2026)
12 Months		 (Jun 27 2025)
12 Months		 (Dec 27 2024)
12 Months		 (Apr 01 2022)
12 Months		 (Dec 31 2021)
12 Months
Y / Y Current Liabilities TTM Growth -68.12 % -59.81 % -59.94 % -42.19 % -34.93 %
Y / Y Cash & cash equivalent TTM Growth -36.57 % -27.19 % 2.96 % 38.75 % 41.21 %
Quick Ratio TTM 1.13 0.78 0.7 0.63 0.57
Total Ranking TTM # 2782 # 3168 # 2795 # 3245 # 3293
Seq. Current Liabilities TTM Growth -36.44 % -28.83 % -26.02 % -4.73 % -19.88 %
Seq. Cash & cash equivalent TTM Growth -7.82 % -21.32 % -17.29 % 5.75 % 5.81 %

Quick ratio ranking by company, industry and sector >> Back to MNKKQ Financial Strength Comparisons >> Go to Compare MNKKQ Quick Ratio to its Competitors

On the trailing twelve months basis Current Liabilities decreased faster than Mallinckrodt Plc's average Cash & cash equivalent, this led to increase in in Mallinckrodt Plc's Quick Ratio to 1.13, above MNKKQ average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 591 other companies have achieved higher Quick Ratio than Mallinckrodt Plc. While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending second quarter 2025 at 5937.

Explain Quick Ratio?
How much Cash & cash equivalents MNKKQ´s has?
What are MNKKQ´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 592
Healthcare Sector # 1185
Within the Market # 3630


trailing twelve months Quick Ratio Statistics
High Average Low
0.87 0.46 0.24
(Mar 27 2015)   (Jun 30 2017)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Major Pharmaceutical Preparations Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Quantum Cyber N v   4.46 $ 13.415  Millions$ 3.005  Millions
Maia Biotechnology Inc   4.41 $ 27.596  Millions$ 6.258  Millions
Azitra Inc   4.40 $ 6.728  Millions$ 1.531  Millions
Cypherpunk Technologies Inc   4.39 $ 7.624  Millions$ 1.737  Millions
Rigel Pharmaceuticals Inc  4.35 $ 225.347  Millions$ 51.858  Millions
Biohaven Ltd   4.28 $ 267.866  Millions$ 62.658  Millions
Longeveron Inc   4.20 $ 18.104  Millions$ 4.307  Millions
Vistagen Therapeutics Inc   4.15 $ 46.439  Millions$ 11.192  Millions
Gyre Therapeutics Inc   4.12 $ 86.289  Millions$ 20.957  Millions
Seaport Therapeutics Inc   4.11 $ 64.423  Millions$ 15.674  Millions
Prelude Therapeutics Inc  3.99 $ 151.757  Millions$ 38.042  Millions
Alx Oncology Holdings Inc  3.97 $ 22.753  Millions$ 5.731  Millions
Actinium Pharmaceuticals Inc  3.94 $ 36.473  Millions$ 9.260  Millions
Veru Inc   3.88 $ 23.880  Millions$ 6.156  Millions
Gain Therapeutics inc  3.81 $ 13.084  Millions$ 3.434  Millions
Bolt Biotherapeutics Inc   3.79 $ 29.823  Millions$ 7.867  Millions
Acurx Pharmaceuticals inc   3.72 $ 10.656  Millions$ 2.865  Millions
Maplight Therapeutics Inc   3.71 $ 71.633  Millions$ 19.294  Millions
Aptevo Therapeutics Inc   3.47 $ 17.997  Millions$ 5.188  Millions
Ataibeckley Inc   3.43 $ 168.807  Millions$ 49.221  Millions
Dogwood Therapeutics inc   3.40 $ 9.628  Millions$ 2.831  Millions
Tvardi Therapeutics Inc   3.39 $ 30.865  Millions$ 9.113  Millions
Biomea Fusion Inc   3.32 $ 34.824  Millions$ 10.483  Millions
Abeona Therapeutics Inc   3.32 $ 146.826  Millions$ 44.233  Millions
Foghorn Therapeutics Inc   3.31 $ 167.582  Millions$ 50.579  Millions
Cingulate Inc   3.29 $ 28.403  Millions$ 8.631  Millions
Unicycive Therapeutics Inc  3.28 $ 61.425  Millions$ 18.704  Millions
Harmony Biosciences Holdings inc   3.17 $ 667.791  Millions$ 210.812  Millions
Pulmatrix Inc   3.15 $ 2.168  Millions$ 0.689  Millions
Nextcure Inc   3.13 $ 20.088  Millions$ 6.413  Millions

Date modified: 2026-09-18T17:35:36+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.